Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
Open Access
- 1 October 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 40 (4), 883-891
- https://doi.org/10.1002/hep.1840400418
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudineAlimentary Pharmacology & Therapeutics, 2003
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJournal of Hepatology, 2001
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Hepatitis B e antigen-negative chronic hepatitis b in Hong KongHepatology, 2000
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defectiveHepatology, 1998
- Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in FranceJournal of Hepatology, 1994
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter studyJournal of Hepatology, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958